21/09/2021

Award-winning science: Cancer-promoting metabolic pathways as targets of new therapies

Christiane Opitz, scientist at the German Cancer Research Center, is being awarded this year's Ita Askonas Prize of the European Federation of Immunological Societies. Opitz has discovered how tumor…

31/08/2021

How adaptations can make cancer treatment more difficult

Each tumor consists of multiple cell types, all of which have distinct characteristics. In addition to determining the course of the disease, these differences between individual cancer cells control…

22/07/2021

New druggable vulnerabillty of colorectal cancer discovered

Colorectal cancer is the second most common tumor disease among women and the third most common among men in Germany. Intestinal tumors often form dangerous metastases in other organs. A team of…

20/07/2021

Why identical mutations cause different types of cancer

Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium (DKTK), the Technical University of Munich (TUM), and the…

29/06/2021

Blood stem cells make brain tumors more aggressive

For the first time, scientists from the German Cancer Consortium (DKTK) partner site in Essen/Düsseldorf have discovered stem cells of the hematopoietic system in glioblastomas, the most aggressive…

18/06/2021

Probing deeper into tumor tissues

Joint press release of Charité and the BIH together with the MDC Researchers at the Charité – Universitätsmedizin Berlin, Max Delbrück Center for Molecular Medicine in the Helmholtz Association…

04/06/2021

Jun.-Prof. Dr. Jakob Nikolas Kather - Heinz Maier-Leibnitz Prizewinner 2021

Jakob Nikolas Kather conducts research in the newly established field of computer-based methods in clinical imaging. The results of his work help further develop the evaluation and interpretation of…

04/06/2021

Hands-on Training for Leadership Skills - Fun Factor Included

This time, the DKTK seminar series on translational research techniques for young scientists was dedicated to the question: "How can I improve my group leadership and teamwork skills at the same…

22/04/2021

ERC Advanced Grant 2021 goes to Prof. Dr. Greten

20/04/2021

A multidimensional view of the coronavirus

What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of…

15/04/2021

Joint forces to combat common diseases - 3rd Joint DZG Symposium in Dresden

April 13th, 2021: Fighting common diseases together! The mission of the German Centers for Health Research (DZGs) is to optimize the translation of research results to their application in patients…

26/03/2021

Vaccination against mutated protein tested in brain tumor patients for the first time

Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated…

24/02/2021

Supposedly "silent" mutation with serious consequences

So-called silent mutations have no effect on the composition of a protein. They are therefore not considered to promote cancer. However, scientists from the German Consortium for Translational Cancer…

23/02/2021

PSMA-Binding Agents: Versatile Against Prostate Cancer

PSMA-binding agents specifically dock onto prostate cancer cells. Coupled to diagnostic or therapeutic radionuclides, they can improve the diagnosis and treatment of prostate cancer. Scientists from…

05/02/2021

Genotoxic E. coli “caught in the act” of transforming primary colon cells

A research team led by Kiel senior professor Thomas F. Meyer reveals transformation of colon organoids in vitro

04/02/2021

When Hyperactive Proteins Trigger Illnesses

Autoimmune diseases, in which the body's own immune system attacks healthy tissue, can be life-threatening and can impact all organs. A research team at the Technical University of Munich (TUM) has…

04/02/2021

A defect with serious consequences: Epigenetic reprogramming turns neural stem cells into drivers of childhood brain tumors

During embryonic brain development, neural stem cells pass through a series of strictly regulated development phases. A mutation in a protein that packs our neatly folded DNA in the cell nucleus…

26/01/2021

Lord of the Rings

Anton Henssen of the ECRC has been awarded the Kind Philipp Award for Pediatric Oncology Research for his study of ring-shaped DNA and its significance in the development of childhood neuroblastoma. A…

22/12/2020

Krebsforscher erhält Leibniz-Preis

Prof. Jürgen Ruland, from TUM’s Rechts der Isar Hospital at the Partner Site of the German Consortium for Translational Cancer Research (DKTK), will receive the 2021 Gottfried Wilhelm Leibniz Prize.…

01/12/2020

Rhine-Main Cancer Retreat 2020

End of October 2020, the annual DKTK Retreat of the partner site Frankfurt/Mainz took place for the 6th time. Joining forces with the Frankfurt Cancer Institute (FCI) and the Mildred Scheel Career…